ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0287 • ACR Convergence 2025

    Comprehensive Profiling of Neutrophil Subsets Reveals Functional Signatures Linked to Vasculopathic Features in Patients with Inflammatory Myopathies

    Daniel Alberto Carrillo-Vázquez1, Beatriz Alcalá-Carmona1, Jennifer Tiaré Balderas Miranda2, Yatzil Reyna Juárez3, María José Ostos Prado1, Samuel Govea-Peláez1, Nancy R Mejía Domínguez4, Guillermo Juárez Vega4, Karina Santana-De Anda1, Jiram Torres-Ruiz5 and Diana Gómez-Martín6, 1Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán, Mexico City, Distrito Federal, Mexico, 2Universidad Nacional Autónoma de México, Coyoacán, Federal District, Mexico, 3Instituto Politècnico Nacional, Tultitlán de Mariano Escobedo, Mexico State, Mexico, 4Universidad Nacional Autónoma de México, Mexico City, Distrito Federal, Mexico, 5INCMNSZ, Ciudad de México, Mexico, 6INCMNSZ, Mexico city, Federal District, Mexico

    Background/Purpose: Vasculopathic manifestations of idiopathic inflammatory myopathies (IIM) such as interstitial lung disease (ILD), calcinosis, skin ulcers, mechanic’s hands, are characterized by immune-mediated vascular damage.…
  • Abstract Number: 0314 • ACR Convergence 2025

    What changes in quality of life can be observed in patients with knee or hip OA prior to total hip or total knee replacement surgery ? data from the KHOALA cohort

    Anne-Christine Rat1, LATOURTE Augustin2, Maud Wieczorek3, Jérémie sellam4, willy Ngueyon Sime5, Jacques Pouchot6, Christian Roux7, Alain SARAUX8, Francis Guillemin9 and Joel Coste10, 1Caen University hospital, UMR 1075 Caen normandy university, Caen, France, 2Rheumatology Department, Lariboisiere Hospital, Paris, France, 3Lausanne Univserty, Lausanne, Switzerland, 4Saint-Antoine hospital, Assistance Publique – Hôpitaux de Paris, Paris, France, Sorbonne University, Paris, France, 5CIC, Epidémiologie Clinique, CHRU-Nancy, Inserm, Université de Lorraine, Nancy, France, nNancy, France, 6HEGP hospital, Assistance Publique-Hopitaux de Paris,, Paris, France, 7CHU Nice, Nice, France, 8CHU Brest, Brest, France, 9CHU Nancy, Nancy, France, 10, Assistance Publique – Hôpitaux de Paris, Paris, France

    Background/Purpose: Few studies have examined how the quality of life (QoL) evolves in patients with osteoarthritis (OA) before undergoing total hip or total knee replacement…
  • Abstract Number: 0246 • ACR Convergence 2025

    Fracture Risk in Intestinal Autoimmune-mediated Diseases Patients: Clinical Insights from REMS

    Marco Di Paola1, Fiorella Anna Lombardi1, Edmund J MacLaughlin2, Maurizio Muratore3, Kathleen Methric4, Gianmarco Del Vecchio5, Giusy Peluso6, Chiara Stomaci7, Roberto Franchini1, Francesco Conversano1, Paola Pisani1 and Sergio Casciaro1, 1Institute of Clinical Physiology, National Research Council, Lecce, Puglia, Italy, 2Rheumatology Associates of Delmarva and BoneVue Diagnostics, Easton, MD, 3ASL- LE, "Vito Fazzi" Hospital, Lecce, Puglia, Italy, 4BoneVue Diagnostics, Catonsville, MD, 5Department of Research and Development, Echolight S.p.a., Lecce, Puglia, Italy, 6Department of Innovative Engineering, University of Salento, Lecce, Puglia, Italy, 7Department of Biological and Envinronmental Sciences and Technologies, University of Salento, Lecce, Puglia, Italy

    Background/Purpose: Intestinal Bowel Diseases (IBD), including Crohn’s (ChD), and Ulcerative Colitis (UCD), along with Celiac (ClD), diseases are chronic inflammatory conditions that primarily affect the…
  • Abstract Number: 0316 • ACR Convergence 2025

    Increased Synovial Inflammation, Xist Escape Gene Expression and Knee Pain in Females with Osteoarthritis

    Bella Mehta1, Miguel Otero2, Michael Mazzucco3, Jenelys Ruiz-Ortega4, Caryn Hale4, Fuadur Omi4, Syed Henah Balkhi5, Purva Singh3, Samantha Lessard3, Wei Wang4, Maryam Aslam4, Tristan Maerz6, Peter Sculco3, Anne-Marie Malfait7, Xiaoshun Li8, Yiyuan Wu9, Shady Younis10, William Robinson11, Daniel Ramirez12, Edward DiCarlo12 and Dana Orange5, 1Hospital for Special Surgery, Weill Cornell Medicine, Jersey City, NJ, 2Hospital For Special Surgery, New York, 3Hospital For Special Surgery, New York, NY, 4The Rockefeller University, New York, 5The Rockefeller University, New York, NY, 6University of Michigan, Ann Arbor, MI, 7Rush University Medical Center, Chicago, 8Hospital For Special Surgery, Ridgewood, NY, 9Weill Cornell Medicine, New York, NY, 10Stanford University, Stanford, CA, 11Stanford University, Palo Alto, CA, 12Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: MRI evidence of synovitis and bone marrow lesions, but not cartilage degeneration associate with pain in osteoarthritis (OA). In this work, we integrated clinical,…
  • Abstract Number: 0339 • ACR Convergence 2025

    Evaluating Discordance between Bilateral Hip Bone Density Measurements in Individuals with Low Bone Mass

    Anupama Shahane1, Nora Sandorfi2 and Alexis Ogdie1, 1University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, USA, Philadelphia

    Background/Purpose: Bone mineral density (BMD) measurement by dual X-ray absorptiometry (DXA) is the basis of World Health Organization (WHO) classification criteria for osteoporosis. Traditionally unilateral…
  • Abstract Number: 0357 • ACR Convergence 2025

    Content validation of patient-reported outcome (PRO) measures for fatigue, physical function and disease activity in Polymyositis (PM)

    Jason Xenakis1, Esther Yi1, Iyar Mazar2, Sarah Knight3, Harriet Makin3, Samantha Wratten3, Rohit Aggarwal4 and Stephanie McKee3, 1Pfizer Inc., New York, United States of America, New York, 2Pfizer, US, New York, 3Clarivate, London, United Kingdom, 4University of Pittsburgh, Rheumatology and Clinical Immunology, Pittsburgh, United States of America, Pittsburgh, PA

    Background/Purpose: Polymyositis (PM) is a subtype of idiopathic inflammatory myopathy (IIM) characterized by muscle inflammation and muscle weakness. Extra muscular manifestations like interstitial lung disease…
  • Abstract Number: 0258 • ACR Convergence 2025

    Performance characteristics of anti-Collagen II antibodies for diagnosing inflammatory and non-inflammatory diseases: a systematic review and meta-analysis

    Karyssa Stonick1, Marcela ferrada2, Alice Fike3, Kaitlin Quinn3, Benjamin Turturice3, Casey Stein4 and Peter Grayson5, 1National Insitute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 2University of Maryland, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 4NIAMS, NIH, Chevy Chase, MD, 5National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Chevy Chase, MD

    Background/Purpose: Anti-collagen II (Col2) antibodies have been clinically and experimentally associated with relapsing polychondritis (RP), rheumatoid arthritis (RA), and other diseases. Whether anti-Col2 antibodies are…
  • Abstract Number: 0348 • ACR Convergence 2025

    Correlation between Bone Mineral Density by Dual-energy X-ray Absorptiometry at the Radius and Radius Cortical Bone Thickness using Routine Hand Radiographs in Rheumatoid Arthritis Patients

    Karla Miller1, Amani Jridi2 and Tina Basak3, 1University of Utah School of Medicine, Salt Lake City, UT, 2University of Utah, Salt Lake City, UT, 3University of Utah Department of Radiology, Salt Lake City, UT

    Background/Purpose: Rheumatoid arthritis (RA) patients are at higher risk of having generalized osteoporosis of the axial and appendicular skeleton assessed by dual-energy x-ray absorptiometry (DXA)…
  • Abstract Number: 0358 • ACR Convergence 2025

    Different Perspectives between Physicians and Patients on Treatment Priorities and Challenges in Still’s Disease

    Gisella Beatrice Beretta1, Luciana Pereira2, Greta Rogani3, Francesco Baldo4, Claudia Bracaglia5, Dirk Foell6, Marco Gattorno7, Marija Jelusic8, Sebastiaan Vastert3, Rashmi Sinha9 and Francesca Minoia10, 1Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Milan, Italy, 2Systemic JIA Foundation, Cincinnati, 3University Medical Center Utrecht, Utrecht, Utrecht, Netherlands, 4ASST-Pini-CTO, Milano, Milan, Italy, 5IRCCS Ospedale Pediatrico Bambino Gesu', Rome, Rome, Italy, 6University Hospital Muenster, Muenster, Germany, 7IRCCS G. Gaslini, Genova, Genoa, Italy, 8University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Zagreb, Croatia, 9Systemic JIA Foundation, Cincinnati, OH, 10Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Milan, Italy

    Background/Purpose: Despite therapeutic advances, major concerns and disparities persist in the care of Still’s Disease (SD). Capturing both patient/caregiver and physician perspectives is essential to…
  • Abstract Number: 0342 • ACR Convergence 2025

    Comparison of Cortical Backscatter Ultrasound, Reference-Point Indentation and Bone Mineral Density in Discriminating Prevalent Fragility Fractures in Inflammatory Rheumatic Diseases: A Pilot Study

    Edgar Wiebe1, Benjamin Kuntz2, Angela Galindo Santos3, Zhivana Boyadzhieva3, Sandra Hermann1, Burkhard Muche2, Andriko Palmowski2, Gerhard Krönke4, Ralf Schmidmaier5, Kay Raum3 and FRANK BUTTGEREIT6, 1Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany, Berlin, Berlin, Germany, 2Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 3Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Berlin, Germany, 4Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, Berlin, Berlin, Germany, 5Klinikum der Universität München, Medizinische Klinik und Poliklinik IV, München, Bayern, Germany, 6Charité University Medicine Berlin, Berlin, Berlin, Germany

    Background/Purpose: Patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) are at elevated risk for osteoporotic fragility fractures. Standard assessment via dual-energy X-ray absorptiometry (DXA) does…
  • Abstract Number: 0243 • ACR Convergence 2025

    Epidemiology of adult-onset Systemic Autoinflammatory Diseases in a well-defined population from northern spain

    Carmen Lasa Teja1, Laura Muñoz-Llopis2, Diana Prieto-Peña3, Isla Morante Bolado4, José Luis Martín-Varillas5, Nerea Paz-Gandiaga6 and Ricardo Blanco7, 1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Riotuerto, Cantabria, Spain, 2Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 3Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Santander, Spain, 4Rheumatology, Hospital General Sierrallana, Torrelavega, Spain., Santander, 5Rheumatology Division, Hospital de Laredo. IDIVAL, Immunopathology Group. Santander, Spain., Laredo, Spain, 6Rheumatology, Hospital Comarcal de Laredo, Laredo, Spain., Santander, 7Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain

    Background/Purpose: Systemic autoinflammatory diseases (SAIDs) are rare disorders characterized by recurrent episodes of fever, serositis, gastrointestinal symptoms, arthritis, and/or skin lesions. In adult-onset SAIDs, clinical…
  • Abstract Number: 0338 • ACR Convergence 2025

    Fractures and Changes in Bone Mineral Density During Two Years of Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis: A Systematic Literature Review and Individual Participant Data Meta-Analysis

    Andriko Palmowski1, Tobias Haugegaard2, Ingiäld Hafstörm3, Henning Bliddal4, Judith Oldenkott5, Siegfried Wassenberg6, Ernest Choy7, John Kirwan8, Robin Christensen9, Maarten Boers10 and FRANK BUTTGEREIT11, 1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 2The Parker Institute, Kopenhagen, Denmark, 3Karolinska Institutet, Stockholm, Sweden, 4The Parker Institute, Frederiksberg, Denmark, 5Charité, Berlin, Germany, 6Rheumazentrum Ratingen, Ratingen, Germany, 7Division of Infection and Immunity, CREATE Centre, Cardiff University, Cardiff, United Kingdom, 8University of Bristol, Bristol, United Kingdom, 9Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen, Hovedstaden, Denmark, 10Amsterdam UMC, Vrije Universiteit, Amersfoort, Netherlands, 11Charité University Medicine Berlin, Berlin, Berlin, Germany

    Background/Purpose: It is unclear to what extent low dose glucocorticoids (GCs) impact bone health in patients with rheumatoid arthritis (RA). RA leads to bone loss…
  • Abstract Number: 0329 • ACR Convergence 2025

    Machine Learning-Based Model to Predict Rapid Structural Progression in Knee Osteoarthritis

    Maria Fernanda Gonzalez Hernandez1, Ignacio rego Pérez2, Isabel Rodríguez Valle3, Jorge Vázquez García4, Vanesa Balboa5, Sara Relaño Fernández4, María C. de Andrés6, Lucía Lourido7, Valentina Calamia7, Rocio Paz González4, Patricia Quaranta7, Patricia Fernández-Puente4, Nicola Veronese8, Cristina Ruiz-Romero9, Natividad Oreiro10 and francisco J Blanco11, 1Instituto de Investigacion Biomedica de A Coruna (INIBIC), A coruña, Galicia, Spain, 2Department of Rheumatology, Rheumatology Research Group (GIR) Biomedical Re-search Institute (INIBIC), A Coruña, Spain, 3Instituto de Investigacion Biomedica de A Coruna (INIBIC), Coruña, Galicia, Spain, 4Instituto de Investigacion Biomedica de A Coruna (INIBIC), coruña, Spain, 5Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, coruña, Spain, 6Instituto de Investigación Biomédica de A Coruña (INIBIC), Grupo de Investigación de Reumatología (GIR), A Coruña, Spain, 7Instituto de Investigacion Biomedica de A Coruna (INIBIC), coruna, Spain, 8Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, palermo, Italy, 9Department of Rheumatology, Rheumatology Research Group (GIR) Biomedical Re-search Institute (INIBIC),, A Coruña, Spain, 10CHUAC, La Coruna, Spain, 11INIBIC-University of A Coruña, A Coruña, Galicia, Spain

    Background/Purpose: Osteoarthritis (OA) is the most common chronic joint disorder, characterized by structural cartilage and bone damage that often causes pain and disability. However, the…
  • Abstract Number: 0305 • ACR Convergence 2025

    From Movement to Meaning: Exploring Physical Function in IBM with Actigraphy

    Vaidehi Kothari1, Eaman Alhassan2, Kevin Renz Ambrocio1, Bonny Rockette-Wagner3, Chester V. Oddis1, Kendrea (Focht) Garand1 and Rohit Aggarwal4, 1University of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh Medical Center, Pittsburgh, PA, 3University of Pittsburgh, PITTSBURGH, 4University of Pittsburgh, Rheumatology and Clinical Immunology, Pittsburgh, United States of America, Pittsburgh, PA

    Background/Purpose: Inclusion body myositis (IBM) is a progressive and severe inflammatory muscle disease that primarily affects adults over 50 years of age. It presents with…
  • Abstract Number: 0335 • ACR Convergence 2025

    Discontinuation and Non-Publication of Osteoarthritis Clinical Studies: A Cross-Sectional Analysis of 10,686,413 Patients

    Mohamed Abdelsalam1, Hadeer Hafez2, Maryam Lasheen3, Bassant Elaraby Elsayed Badwy4, Omar Sameh Nabil El Sedafy1, Abdelrahman M Hafez5, Omnia Samy El-Sayed4, Menat Alla Ayman Ali Mahdy4, Ali Tarek Hassanin3, Mohamed Reda Awad6 and Mohammed Safwat Kamal Hamza7, 1Misr University For Science and Technology, 6 october, Al Jizah, Egypt, 26th October University, 6 october, Al Jizah, Egypt, 3Misr University For Science and Technology, Helwan, Al Qahirah, Egypt, 4Misr University For Science and Technology, Nasr City, Al Qahirah, Egypt, 5Faculty of medecine, Damietta university, Mansoura, Ad Daqahliyah, Egypt, 6Al Azhar University, Cairo, Egypt, Giza, Al Jizah, Egypt, 7Faculty of Medicine, Misr University for Science and Technology, 6 october, Al Jizah, Egypt

    Background/Purpose: Osteoarthritis (OA) is rising at an alarming rate, affecting millions worldwide and threatening mobility, independence, and quality of life. High-quality evidence is essential to…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology